Caroline Goldin, MD
Neurology · New Orleans, LANPI 1891189296
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (46.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Novocure Inc. at 48.6% of the total. Among neurology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $864.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$18K
- Medtronic$9K
- Boston Scientific$8K
- AstraZeneca$2K
- Day One Biopharmaceuticals$15
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$2K
What the payments were for
- Consulting fees$14,80041%
- Speaking & faculty fees$1,5004%
- Grants$16,87546%
- Travel & lodging$1,1403%
- Food & beverage$1,9986%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 36 | $17,639 |
| Medtronic(2 entities) | 2 | $9,483 |
| Boston Scientific | 2 | $7,625 |
| AstraZeneca | 1 | $1,550 |
| Day One Biopharmaceuticals | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune Gio$14,948
- ACTIVA$9,375
- VERCISE$7,500
- KOSELUGO$1,550
- Optune$444
- TheraSphere Y90 Glass Microspheres 10 GBq$125
- Pipeline$108
How this compares
$36,312 in reported general payments places this provider in the 90th percentile of 225 neurology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Everolimus | 16 | $26,138 |
| GleostineLomustine | 11 | $11,280 |
| EliquisApixaban | 16 | $9,045 |
| Lacosamide | 15 | $2,870 |
| Levetiracetam | 66 | $2,248 |
| Primidone | 18 | $1,157 |
| Dexamethasone | 33 | $555 |
| RivastigmineRivastigmine Tartrate | 16 | $529 |
| Sertraline Hcl | 11 | $381 |
| Oxcarbazepine | 11 | $360 |
| Gabapentin | 31 | $271 |
| Baclofen | 13 | $252 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $185 |
| Ondansetron Hcl | 31 | $158 |
| Clonazepam | 15 | $155 |
Paid to pharmacies, not to this prescriber.
Other neurology in New Orleans
- John EnglandNew Orleans$268K
- Brian CopelandNew Orleans$211K
- Bridget BagertNew Orleans$198K
- Sheryl Martin-SchildNew Orleans$106K
- Piotr OlejniczakNew Orleans$82K
- Elizabeth CrabtreeNew Orleans$36K
- Jesus LoveraNew Orleans$27K
- Julia StaischNew Orleans$22K
- Pooja Mohan RaoNew Orleans$17K
- Ronald FioreNew Orleans$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.